Welcome to our dedicated page for Charles & Colvard news (Ticker: CTHR), a resource for investors and traders seeking the latest updates and insights on Charles & Colvard stock.
Charles & Colvard, Ltd. (Nasdaq: CTHR) is a pioneer in the fine jewelry industry, recognized globally as the original creator of lab-grown moissanite. Since its inception in 1995, the company has been synonymous with innovation, quality, and ethical practices. Headquartered in North Carolina's Research Triangle Park, Charles & Colvard produces and markets created gems and fine jewelry using exclusively Made, not Mined™ above-ground gemstones and 100% recycled precious metals.
Charles & Colvard's flagship products include the Forever Classic™, Forever Brilliant®, and Forever One™ moissanite gems. These gems exhibit superior fire, brilliance, and sparkle compared to fine diamonds, yet are available at a fraction of the cost. The company also offers Caydia® lab-grown diamonds, catering to a variety of jewelry needs from bridal to high fashion and everyday wear.
The company's operations are divided into two segments: the Online Channels and the Traditional segments. Through its e-commerce outlets—including charlesandcolvard.com and moissaniteoutlet.com—Charles & Colvard generates the majority of its revenue. It also sells its products through third-party online marketplaces, drop-ship retail, and other exclusively e-commerce outlets. In addition to online sales, their jewelry is distributed through fine jewelry stores, shopping networks, and catalogs, both domestically and internationally.
In recent developments, Charles & Colvard has reported a strong financial condition despite industry challenges. As of the latest fiscal quarter, the company maintains a robust cash position with no debt, ensuring stability and confidence among shareholders. The company has also announced strategic initiatives, including a new digital B2B trade portal, Charles & Colvard Direct, aimed at supporting independent jewelers and retailers. This platform offers the company's premium moissanite brands directly to the trade, bypassing traditional distributor models.
Another notable achievement is the exclusive strategic alliance with the International Gemological Institute (IGI). This collaboration introduces comprehensive grading reports for Charles & Colvard's moissanite gemstones, enhancing consumer confidence by providing standardized measures of quality and authenticity.
Charles & Colvard remains committed to its mission of delivering exquisite, ethical jewelry. Recent partnerships, such as the endorsement by actress Skyler Samuels, aim to enhance brand awareness and consumer education on the benefits of choosing lab-grown gems.
For more information, please visit www.charlesandcolvard.com.
Charles & Colvard (NASDAQ: CTHR) has received an interim arbitration award in its dispute with Wolfspeed, Inc. The arbitrators significantly reduced Wolfspeed's original damage claims of $28 million to $3.3 million, consisting of $1.3 million for previously purchased inventory and $2.0 million for consigned inventory. The ruling requires CTHR to pay 8% annual interest from April 24, 2023, arbitration fees, and attorney's fees, excluding costs related to expectation damages claims.
The company views this as a significant victory, as it eliminates a long-term purchase commitment that management believed was hampering growth and profitability. The $2.0 million consigned inventory payment will be recorded as an asset on the company's balance sheet as of June 30, 2024. Wolfspeed must submit its attorney's fees petition by January 4, 2025, with CTHR having 15 days to respond.
Charles & Colvard (Nasdaq: CTHR) received a non-compliance notice from Nasdaq on November 21, 2024, for failing to timely file its Q1 FY2025 Form 10-Q and FY2024 Form 10-K. The company has until December 17, 2024, to either regain compliance or submit a compliance plan. If Nasdaq accepts the plan, CTHR may receive up to 180 calendar days (until April 14, 2025) to file the required documents. While the notice doesn't immediately affect CTHR's Nasdaq listing, the company must address these filing delays to maintain its listing status.
Charles & Colvard (Nasdaq: CTHR) has received a non-compliance notice from Nasdaq on October 18, 2024, for failing to timely file its Annual Report (Form 10-K) for the fiscal year ended June 30, 2024. The filing was due September 30, 2024. The company has until December 17, 2024 to either regain compliance or submit a compliance plan. If Nasdaq accepts the plan, CTHR may receive an extension until April 14, 2025. The notice does not immediately affect CTHR's Nasdaq listing. The company states it is working to complete and file the Form 10-K promptly.
Charles & Colvard, (Nasdaq: CTHR) has responded to a letter from Riverstyx Capital Management regarding director nominations. The company stated that a purported nomination notice from Ben Franklin, a Riverstyx principal, is invalid and will not be recognized. The notice, received on August 27, failed to comply with the company's bylaws by omitting critical information such as candidate biographies, ownership stakes, and candidate consents.
The company's board has invited Mr. Franklin to share his perspectives on the business and strategy directly. Charles & Colvard will make recommendations to shareholders regarding the upcoming Annual Meeting and director elections in due course. Shareholders are not required to take any action at this time.
Charles & Colvard (Nasdaq: CTHR), a notable fine jewelry company specializing in moissanite and lab-grown diamonds, announced on June 6, 2024, that it has regained compliance with Nasdaq's minimum bid price listing requirement. As of May 31, 2024, the company's common stock maintained a minimum bid price of $1.00 per share or greater for 10 consecutive business days. Consequently, the company has met the requirements of Listing Rule 5550(a)(2), officially closing the matter.
Charles & Colvard (Nasdaq: CTHR) has announced an exclusive alliance with the International Gemological Institute (IGI) to provide grading reports for moissanite gemstones and jewelry. This collaboration aims to enhance consumer confidence by offering standardized measures for authenticity and quality. The grading reports will include detailed assessments by expert gemologists using the 4Cs criteria and additional moissanite-specific measures. The initiative targets combating false information and counterfeit products in the market. The reports will initially be available to the trade and later to consumers. Both companies will showcase this development at the JCK Show in Las Vegas from May 31 – June 3, 2024.
Charles & Colvard (Nasdaq: CTHR), a renowned fine jewelry company, announced a one-for-ten (1:10) reverse stock split of its common stock. Effective May 17, 2024, this move aims to comply with Nasdaq’s $1.00 minimum bid price requirement. Post-split, the number of shares will reduce from approximately 30 million to 3 million, with no fractional shares issued. The company's ticker remains 'CTHR'. Shareholders approved the proposal on May 7, 2024, and the North Carolina Secretary of State filed the Articles of Amendment on May 14, 2024. The company’s stock options and equity awards will adjust proportionately.
Charles & Colvard, a fine jewelry company specializing in moissanite and lab-grown diamonds, reported third-quarter fiscal year 2024 financial results. Despite a challenging quarter, the company remains focused on growth through strategic initiatives and technology investments. They saw growth in repeat customers and positive responses to new products and marketing efforts. The company introduced new gemstone brands, expanded product lines, and partnered with a celebrity brand ambassador. However, they experienced a 21% decrease in net sales, primarily in the Traditional segment. Gross profit margin declined to 23%, and operating expenses increased by 13%. The net loss was $3.6 million for the quarter, with cash and inventory decreasing.
FAQ
What is the current stock price of Charles & Colvard (CTHR)?
What is the market cap of Charles & Colvard (CTHR)?
What is Charles & Colvard known for?
What are the primary products offered by Charles & Colvard?
How does Charles & Colvard sell its products?
What recent strategic initiatives has Charles & Colvard announced?
Who is the current brand ambassador for Charles & Colvard?
What is the significance of the partnership with the International Gemological Institute (IGI)?
What is the company's approach to ethical jewelry?
How has the company performed financially in recent quarters?
What are some of the company's key marketing strategies?
Where can I find more information about Charles & Colvard?
